Journal of Hematology & Oncology

official impact factor 2.93

Open Access Research

SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status

Ayad M Al-Katib*, Yuan Sun, Anton S Goustin, Asfar S Azmi, Ben Chen, Amro Aboukameel and Ramzi M Mohammad

Journal of Hematology & Oncology 2009, 2:8 doi:10.1186/1756-8722-2-8

No comments have yet been made on this article.

Post a comment